web analytics
27.4 C
Karachi
Sunday, August 10, 2025
PSL 10
PSX
Gold Rates
Currency Exchange
HomeTagsRoche

All Stories: Roche

Roche has no plans for job cuts and business is healthy

Swiss pharmaceutical company Roche is not planning job cuts and its business is healthy, CEO Thomas Schinecker was quoted as saying by a Swiss...

Blood pressure drug succeeds in mid-stage trial

Roche and partner Alnylam said on Tuesday their experimental drug against high blood pressure was shown to work when used in combination with...

Roche joins race for obesity drugs with $2.7 billion

Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the...

Roche’s bid to retool Actemra for COVID-19 fails

Roche launched the 330-patient trial in March as it joined other pharmaceutical companies seeking to re-purpose existing medicines to fight the pandemic

Pharma wins US nod for COVID-19 antibody test

Roche’s head of diagnostics, said the company aims to more than double production of tests from about 50 million a month to significantly more than 100 million a month by the end of the year

New flu drug can drive resistance in influenza viruses

The Swiss drugmaker is seeking to establish Xofluza, which has a list price of $150, as a more convenient alternative to its older Tamiflu

Pharma firm wins approval for personalised cancer drug

Roche is also testing Rozlytrek in cancers with additional genetic anomalies

Roche sues US executives in fight over diabetes test strips

Roche is seeking damages and compensation in a U.S. lawsuit against former executives of a Utah-based company, the Swiss drugmaker’s latest case targeting what it calls fraudulent schemes involving its diabetes test strips.

Roche, joining rivals, donates hemophilia drug to boost access

Roche’s donation will focus on patients who have developed resistance, or inhibitors, to current hemophilia A treatments as well as children, the Basel-based company said in a statement.

Roche CEO says new drugs will offset biosimilar incursions

ZURICH: Swiss drugmaker Roche will be able to compensate or overcompensate for falling revenue from patent-expired drugs facing competition from rivals’ copies through its...

Roche’s emicizumab haemophilia drug succeeds in trial

SHANGHAI: Roche Holding AG's emicizumab drug for treating haemophilia A showed it worked in a phase III study, the Swiss drugmaker said on Thursday. Roche...

Roche lung cancer drug success adds to pressure on Bristol

COPENHAGEN: Lung cancer patients on Roche's immune system-boosting drug Tecentriq lived on average 4.2 months longer than those taking chemotherapy in a pivotal study,...

Roche to buy U.S. biotech firm InterMune for $8.3 billion

LONDON/ZURICH: Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.
-Advertisement-
 

Trending

BREAKING NEWS

MUST READ

ABOUT US

ARY NEWS brings you 24/7 Live Streaming, Headlines, Bulletins, Talk Shows, Infotainment, and much more. Watch minute-by-minute updates of current affairs and happenings from Pakistan and all around the world!

CORPORATE

ARY NETWORK

DOWNLOAD NOW!

© 2025 ARYNEWS.tv. All Rights Reserved.